ArticleBreast cancer research and treatment2024

The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system.

Jenna Bhimani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.